NCT06344130View on ClinicalTrials.gov

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
AstrocytomaGliomaRecurrent Glioblastoma
Interventions
RADIATION

Radiation Therapy

Radiation therapy will be administered via a linear accelerator using 6 megavoltage (MV) photons or greater.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH